文献
J-GLOBAL ID:201102223067180029
整理番号:11A1462079
不応性副腎皮質癌患者における抗-IGF-1Rモノクローナル抗体フィギツムマブの安全性、忍容性および薬物動態
Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinoma
著者 (10件):
HALUSKA Paul
(Mayo Clinic Coll. of Medicine, Div. of Medical Oncology, 200 First Street SW, 55905, Rochester, MN, USA)
,
WORDEN Frank
(Univ. of Michigan Medical School, BSRB 1502, 109 Zina Pitcher Place, 48109-2200, Ann Arbor, MI, USA)
,
OLMOS David
(Royal Marsden NHS Foundation Trust, London, GBR)
,
YIN Donghua
(Pfizer Global Res. and Dev., New London, CT, USA)
,
SCHTEINGART David
(Univ. of Michigan Medical School, BSRB 1502, 109 Zina Pitcher Place, 48109-2200, Ann Arbor, MI, USA)
,
BATZEL Gretchen N.
(Mayo Clinic Coll. of Medicine, Div. of Medical Oncology, 200 First Street SW, 55905, Rochester, MN, USA)
,
PACCAGNELLA M. Luisa
(Pfizer Global Res. and Dev., New London, CT, USA)
,
BONO Johann S.
(Royal Marsden NHS Foundation Trust, London, GBR)
,
GUALBERTO Antonio
(Pfizer Global Res. and Dev., New London, CT, USA)
,
HAMMER Gary D.
(Univ. of Michigan Medical School, BSRB 1502, 109 Zina Pitcher Place, 48109-2200, Ann Arbor, MI, USA)
資料名:
Cancer Chemotherapy and Pharmacology
(Cancer Chemotherapy and Pharmacology)
巻:
65
号:
4
ページ:
765-773
発行年:
2010年03月
JST資料番号:
D0065D
ISSN:
0344-5704
CODEN:
CCPHDZ
資料種別:
逐次刊行物 (A)
発行国:
ドイツ (DEU)
言語:
英語 (EN)